Terzepatide 60mg
Tirzepatide 60 mg usually refers to a multi-dose peptide vial or pen containing 60 mg of tirzepatide, the same active ingredient used in the medications Mounjaro and Zepbound. These drugs are prescribed for type 2 diabetes and weight loss.
How Tirzepatide works
Tirzepatide is a dual-incretin agonist that activates two hormone receptors:
GLP-1 receptor → reduces appetite and slows stomach emptying
GIP receptor → improves insulin sensitivity and glucose control
This combination often produces significant weight loss and blood-sugar control compared with older GLP-1 drugs.
What “60 mg” means
A 60 mg vial/pen is not a single dose. It’s a total amount of drug that is divided into weekly injections.
Typical weekly dosing schedule used medically:
| Week | Dose |
|---|---|
| Weeks 1–4 | 2.5 mg weekly |
| Weeks 5–8 | 5 mg weekly |
| Weeks 9–12 | 7.5 mg weekly |
| Weeks 13+ | 10–15 mg weekly (if tolerated) |
With 60 mg total, the supply length depends on the dose:
2.5 mg/week → ~24 weeks
5 mg/week → ~12 weeks
10 mg/week → ~6 weeks
15 mg/week → ~4 weeks
Common side effects
Similar to other GLP-1 medications:
nausea
vomiting
diarrhea or constipation
loss of appetite
acid reflux
fatigue
Serious but rare risks include pancreatitis and gallbladder problems.
Important
Only Eli Lilly manufactures approved tirzepatide products (Mounjaro/Zepbound).
Many 60 mg vials sold online are compounded or research peptides, which may vary in quality or sterility.
